Robert Rosenthal

Robert Rosenthal

Direttore/Membro del Consiglio presso BRUKER CORPORATION

Patrimonio netto: 2 M $ in data 31/05/2026

69 anni
Health Technology
Consumer Services
Technology Services

Profilo

Robert J.
Rosenthal
is Chairman at Galvanic Applied Sciences, Inc. since 2013.
Chairman & Chief Innovation Officer at Taconic Biosciences, Inc. since 2019.
Chairman at Taconic Biosciences A since 2014.
Chairman at Trace Bioanalytics LLC.
Chairman at Care Everywhere LLC since 2022.
Director at Matritech, Inc. Independent Director at Bruker Corp.
since 2015.
Director at Cambrius, Inc., The Echo Group, Inc., Bruker Daltonics, Inc., and Pathogenica, Inc. Former President & Chief Executive Officer at Alseres Pharmaceuticals, Inc. from 2002 to 2003.
President, Chief Executive Officer & Director at TekCel, Inc. from 2003 to 2007.
President, Chief Executive Officer & Director at Magellan Diagnostics, Inc. from 2005 to 2009.
President & Chief Executive Officer at Magellan Discovery Technologies LLC from 2001 to 2002.
President & Chief Executive Officer at Magellan Biosciences, Inc. from 2005 to 2009.
Chairman at Safeguard Scientifics, Inc. from 2020 to 2022.
Chairman at Sensor Innovations, Inc. Former Chairman at IMI Intelligent Medical Implants AG from 2012 to 2013.
Director at PrimeraDx, Inc., MZT Holdings, Inc., and Independent Director at Invivo Therapeutics Holdings Corp.
President at Nicolet Instrument Corp.
President-Instrument Division & Senior VP at Perkin Elmer Corp.
from 1999 to 2000.
Education includes an MBA from Stanford University, a doctorate from Emory University, undergraduate studies at the University of Maryland, and graduate studies at The State University of New York.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
01/04/2026 34.261 ( 0,02% ) 2 M $ 31/05/2026

Posizioni attive di Robert Rosenthal

SocietàPosizioneInizio
BRUKER CORPORATION Direttore/Membro del Consiglio 11/11/2015
Direttore/Membro del Consiglio -
Presidente 03/12/2014
Direttore/Membro del Consiglio -
Presidente 01/01/2013
Presidente 14/01/2019
Presidente -
Pathogenica, Inc.
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 25/09/2009
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Robert Rosenthal

SocietàPosizioneFine
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Robert Rosenthal

Formazione di Robert Rosenthal

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

67

Relazioni di 1° grado

28

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private28

Health Technology

Finance

Health Technology

Health Technology

Electronic Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Health Technology

Technology Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Distribution Services

Health Technology

Magellan Discovery Technologies LLC

Commercial Services

Health Technology

Pathogenica, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Robert Rosenthal
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA